Sharper gene scissors for the biotechnology toolbox

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

S’pore’s bioethics advisory committee urges caution on heritable gene editing

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.
Frontiers

From Molecular Regulation to Breeding Applications in Horticultural Crops

Molecular regulatory mechanisms play a crucial role in efficient and precise breeding of horticultural crops, including ...
Frontiers

Elevating Neglected Crops: Gene Editing Approaches to Address Global Food Security Challenges

In the realm of agricultural research, the focus on neglected crops has been comparatively minimal despite their potential to contribute significantly to ...
eLife

Rewiring the bone marrow: Evolution and the transcriptional architecture of trained immunity

Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
India West

Vertex, CRISPR Therapeutics Land On TIME’s Most Influential Companies List

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

How tailored genetic therapy offers hope for rare disorders

Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...